AzTrials
AzTrials

Error DisclosureNCT04659265

A Priori Diagnosis and Diagnostic Errors

A study testing Suspected diagnosis of a pre-treating physician in people with Error Disclosure and Diagnoses Disease, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective randomized single-blind simulator-based trial. 156 4th year medical students were randomised to receive one of three different suspected diagnoses of a pre-treating physician (no diagnosis, myocardial infarction, pulmonary embolism) prior to the task to make a focussed assessment and perform… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
Suspected diagnosis of a pre-treating physician
Could I receive a placebo?
No, everyone receives an active treatment
How many people
156 participants
Where
1 siteSwitzerland
Study dates
Jan 2011to Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • 4th year medical students and physicians taking part in simulation workshops

Who cannot join

  • no consent given to video-tape simulation and analyse vide recordings for scientific purpose

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Medical Intensive Care; University of Basel

    Basel, Canton of Basel-City, 4031

Other trials in Switzerland

About this study

Official title: The Effect of a Wrong Suspected Diagnosis of a Pre-treating Physician on the Correctness of the Final Diagnosis

This is a prospective randomized single-blind simulator-based trial. 156 4th year medical students were randomised to receive one of three different suspected diagnoses of a pre-treating physician (no diagnosis, myocardial infarction, pulmonary embolism) prior to the task to make a focussed assessment and perform first management steps in a patient presenting to the emergency department. The patient (simulator) suffered from an acute myocardial infarction. Video recordings were obtained during simulation and used for data analysis. Primary endpoint was the participants' final presuptive diagnosis.

Read the detailed description

Methods:

Study design:

This is a prospective randomized controlled single-blind trial, the participants not being aware of the purpose of the study. The trial was approved by the regional ethical committee (EKNZ 85/04) and all participants gave written informed consent.

Participants:

Medical students in their 4th year at the University of Basel, Switzerland were offered to participate in voluntary workshops at the simulator centre of the medical intensive care unit of university of Basel hospital. The present study was conducted as part of these workshops.

At the beginning of the workshop participants were asked to fill in a questionnaire. The questionnaire included a) the Big Five personality traits (neuroticism, extraversion, openness, agreeableness, conscientiousness) (McCrae 1992); b) Rosenberg's self-esteem scale(Colani); c) the task to diagnose the cardiac rhythm in 12 one-lead ECG rhythms strips (each correct diagnosis was counted as one point resulting in a maximum of 12 attainable points); d) the task to list the typical symptoms of an acute myocardial infarction in bullet point form (each of the following items were counted as one point resulting in a maximum of 6 attainable points: chest pain; radiation of the pain; pain described as constricting, compressing, or squeezing; at least one accompanied vegetative symptom; dyspnoea; and fear); and e) the task to list the typical signs symptoms of 4 further medical emergencies (anaphylactic shock, trauma management, cardiac arrest, syncope) in bullet point form (answers were coded using a predefined checklist).

Simulator and Scenario:

The study was conducted using a patient simulator. All participants received a standardised instruction of the patient simulator (human patient simulator, Leardal SimMan®). This simulator's features include among others palpable pulses, spontaneous breathing with visible thoracic excursions, spontaneous movements of the eye lids and a speaker in the mannequin's head that broadcasts the voice of a remote operator, allowing for verbal interaction with the participants. For the present trial, the operator was an experienced physician.

For the study scenario participants were given the role of a resident-on-call in the emergency department and were instructed by a senior physician (confederate) to triage a newly arrived patient. Upon entering the simulator room, the participants encountered the patient (simulator) lying on a bed and dressed in a hospital gown. Participants were assisted by a confederate nurse. The nurse was instructed to display a helpful manner, to act only on command, but not to interfere in any way with the assessment and history taking.

Intervention:

All participants performed the scenario on their own and faced a patient with a simulated acute myocardial infarction. Participants were randomized (computer-generated numbers) to three versions of the scenario. The three versions differed only in the reply of the patient to the initial question about the reason for his visit. The patient volunteered that he had phoned his family physician because of acute chest pain and dyspnoea. The family physician had recommended urgent visit of the emergency department because he judged the situation as 1) medical emergency (control group with no à priori diagnosis); 2) acute myocardial infarction (correct à priori diagnosis group); or, 3) acute pulmonary embolism (wrong à priori diagnosis group). Apart from this randomly allocated initial information, the scenario was identical in all groups: until the end of the scenario, the patient only spoke when asked a question and all answers were given according a pre-scripted answer check-list (table) Participants of the groups with no à priori diagnosis and correct à priori diagnosis were given 4 minutes study time. Participants of the group with wrong diagnosis were given one additional minute (i.e. 5 minutes study time) to compensate for probing the given diagnosis. At the end of the study time, the senior physician entered the room and announced that he required the participant to temporarily leave his/her patient to help with another emergent case. The participants were then asked on their presumptive diagnosis and which measures, if any, the nurse should take during their temporary absence during the next couple of minutes.

Data analysis:

Data analysis was performed using video recordings obtained during simulations. Video recordings were analysed independently by two trained raters who noted all questions asked and all measures taken by the participant. Inter-observer differences were solved by jointly re-watching the video recordings.

Statistics:

The primary endpoint was a correct presumptive diagnosis of an acute myocardial infarction or acute coronary syndrome when asked at the end of the scenario by the senior physician or when previously revealed to the patient and/or the nurse. Mentioning the correct diagnosis as possible differential diagnosis was rated as correct diagnosis. A co-primary endpoint was the composite endpoint of a correct presumptive diagnosis OR ordering a 12-lead ECG, the rationale being that a timely 12-lead ECG will most likely prevent harm to a patient not correctly triaged as suffering from acute myocardial infarction.

Secondary endpoints were the number and kind of questions asked during history taking; probing of the à priori diagnosis; measures taken during assessment; and the results of the questionnaire. Results of the knowledge part of the questionnaire are reported as percentages of the attainable maximum.

A 20% difference in the primary outcome was considered to be of medical relevance- A power analysis revealed that approximately 150 teams (50 per group) had to be included to detect this difference with a power of 0.9 at the 0.05 significance level.

Statistical analysis was performed by SPSS (version 25). Non-parametric ANOVA, Mann-Whitney test, chi-square test, Univariate and Multivariate regression analysis, and Cohen's kappa were used as appropriate. A p < 0.05 was considered to represent statistical significance. Data are reported as median [Interquartile range {IQR}] unless otherwise stated.

Being tested
Suspected diagnosis of a pre-treating physician
Keywords
diagnostic error, presumptive diagnosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Suspected diagnosis of a pre-treating physicianOther

    Participants receive the information that the pre-treating physician thought the patient is suffering from a medical emergency (no diagnosis), an acute myocardial infarction (correct diagnosis) or a pulmonary embolism (wrong diagnosis)

Study groups in NCT04659265
Study groupRoleWhat they receive
No suspected diagnosis (control group)Active comparatorParticipants receive the information that the pre-treating physician thought that the patient is suffering from a medical emergency (no diagnosis).
Receives: Other: Suspected diagnosis of a pre-treating physician
Correct suspected diagnosisActive comparatorParticipants receive the information that the pre-treating physician thought that the patient is suffering from an acute myocardial infarction (correct diagnosis).
Receives: Other: Suspected diagnosis of a pre-treating physician
Wrong suspected diagnosisActive comparatorParticipants receive the information that the pre-treating physician thought that the patient is suffering from a pulmonary embolism (wrong diagnosis).
Receives: Other: Suspected diagnosis of a pre-treating physician

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correct diagnosis

    Correct presumptive diagnosis

    Measured: 5 minutes

Secondary outcomes (2)
  1. number and kind of questions asked during history taking

    number and kind of questions asked during history taking

    Measured: 5 minutes

  2. probing of the à priori diagnosis

    questions related to the given à priori diagnosis

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2020
  2. Study startJan 2011
  3. Primary completionJun 2019
  4. Study completionFeb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
156 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04659265
Sponsor's protocol ID
4031-Sim-1
Status last verified
Dec 2020
First submitted
25 Nov 2020
Last updated
9 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The core data of the study are video-recordings of a simulation. These data cannot be shared as they are strictly confidential as indicated in the participants' consent forms.

Questions about this trial

What is this clinical trial studying?

A study testing Suspected diagnosis of a pre-treating physician in people with Error Disclosure and Diagnoses Disease, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correct diagnosis (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2020; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in